Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Depreciation & Amortization (CF) (2016 - 2017)

Historic Depreciation & Amortization (CF) for Tenax Therapeutics (TENX) over the last 8 years, with Q4 2017 value amounting to $3022.0.

  • Tenax Therapeutics' Depreciation & Amortization (CF) fell 3164.44% to $3022.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $13621.0, marking a year-over-year decrease of 2812.9%. This contributed to the annual value of $8000.0 for FY2023, which is 5555.12% up from last year.
  • Latest data reveals that Tenax Therapeutics reported Depreciation & Amortization (CF) of $3022.0 as of Q4 2017, which was down 3164.44% from $3143.0 recorded in Q3 2017.
  • In the past 5 years, Tenax Therapeutics' Depreciation & Amortization (CF) ranged from a high of $2.3 million in Q1 2014 and a low of $3022.0 during Q4 2017
  • Over the past 5 years, Tenax Therapeutics' median Depreciation & Amortization (CF) value was $22300.0 (recorded in 2014), while the average stood at $488395.6.
  • Per our database at Business Quant, Tenax Therapeutics' Depreciation & Amortization (CF) plummeted by 9899.53% in 2014 and then surged by 6037.22% in 2015.
  • Quarter analysis of 5 years shows Tenax Therapeutics' Depreciation & Amortization (CF) stood at $2.3 million in 2013, then crashed by 98.35% to $37893.0 in 2014, then plummeted by 66.62% to $12650.0 in 2015, then tumbled by 65.05% to $4421.0 in 2016, then plummeted by 31.64% to $3022.0 in 2017.
  • Its Depreciation & Amortization (CF) stands at $3022.0 for Q4 2017, versus $3143.0 for Q3 2017 and $3424.0 for Q2 2017.